Loading...
Bioactive nanotherapeutic trends to combat triple negative breast cancer
The management of aggressive breast cancer, particularly, triple negative breast cancer (TNBC) remains a formidable challenge, despite treatment advancement. Although newer therapies such as atezolizumab, olaparib, and sacituzumab can tackle the breast cancer prognosis and/or progression, but achiev...
Na minha lista:
| Udgivet i: | Bioact Mater |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
KeAi Publishing
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970221/ https://ncbi.nlm.nih.gov/pubmed/33778204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bioactmat.2021.02.037 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|